Rolando Perez Rodriguez

This inventor holds 16 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Centro De Inmunologia Molecular, Biocon Limited, Centro De Immunologia Molecular. Active years: 1998-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rolando Perez Rodriguez. Retrieved from https://idiyas.com/inventor/rolando-perez-rodriguez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 2)

% Patents Active = 93.8

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 5.7

ph-index = 7

Forward Citations = 465(Granted Patents)

Location History:

Vibora, CU (1998)
Habana, CU (1998 - 2003)
Havana, CU (1999 - 2010)
Cuidad Habana, CU (2013)
Cuba, CU (2013)
Ciudad De La Habana, CU (2015 - 2024)

Company Filing History:

9 out of 24

Centro De Inmunologia Molecular

Centro De Immunologia Molecular

patents

4. 1 out of 1

Biocon Limited & Centro De Immunologia Molecular

patent

5. 1 out of 2

Centro De Immunologia Molecular (Cim)

patents

6. 1 out of 1

Centro De Inmunolgia Molecular

patent

7. 1 out of 5

Centro De Inmunologia Molecular (Cim)

patents

where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11981743 - Monoclonal antibody and a method thereof (2024-05-14),

2. 10669346 - Monoclonal antibody and a method thereof (2020-06-02),

3. 10000573 - Monoclonal antibody and a method thereof (2018-06-19),

4. 9670285 - Monoclonal antibody and a method thereof (2017-06-06),

5. 9217037 - Monoclonal antibody and a method thereof (2015-12-22),

6. 8563003 - Method for the treatment of malignant and infectious chronic diseases (2013-10-22),

7. 8524233 - Monoclonal antibody and a method thereof (2013-09-03),

8. 7776342 - Preparations that potentiate immunogenicity in low immunogenic antigens (2010-08-17),

9. 6572857 - Anti-CD6 monoclonal antibodies and their uses (2003-06-03),

10. 6433148 - Monoclonal anti-idiotypic antibodies (AB2) and their uses (2002-08-13),

11. 6149921 - Vaccine compositions for eliciting an immune response against (2000-11-21),

12. 6063379 - Anti-idiotypic monoclonal antibodies and compositions including the (2000-05-16),

13. 5891996 - Humanized and chimeric monoclonal antibodies that recognize epidermal (1999-04-06),

14. 5817513 - Anti ganglioside monoclonal antibodies (1998-10-06),

15. 5788985 - Vaccine composition for eliciting an immune response against (1998-08-04),

Certainly! Here is the article about inventor Rolando Perez Rodriguez:

Title: Innovator Spotlight: Rolando Perez Rodriguez

Introduction:

Rolando Perez Rodriguez, a distinguished inventor hailing from Ciudad de la Habana, Cuba, has made significant contributions to the field of biotechnology with his remarkable inventions. With an impressive portfolio of 15 patents, Rodriguez continues to push the boundaries of scientific innovation.

Latest Patents:

Among his latest patents is the groundbreaking invention of a monoclonal antibody and its method. This innovative creation involves a humanized IgG1 isotype anti-CD6 antibody (T1h) designed to target the Scavenger receptor cysteine-rich (SRCR) domain 1 (D1) of CD6 found on various cell types, including thymic epithelial cells, monocytes, and activated T cells.

Career Highlights:

Rodriguez has showcased his expertise and dedication while working at reputable organizations such as Centro De Inmunologia Molecular and Biocon Limited. His tenure at these institutions has been marked by a relentless pursuit of excellence in the field of biotechnology, leading to the development of groundbreaking solutions that have the potential to transform the industry.

Collaborations:

Throughout his career, Rodriguez has collaborated closely with esteemed professionals in the field, including his coworkers Josefa Lombardero Valladares and Jose Enrique Montero Casimiro. These collaborations have been instrumental in fostering a culture of innovation and driving forward-thinking research initiatives.

Conclusion:

In conclusion, Rolando Perez Rodriguez stands as a testament to the power of innovation and the impact that dedicated inventors can have on society. His trailblazing work in the field of biotechnology serves as a source of inspiration for aspiring inventors and underscores the importance of pushing the boundaries of scientific exploration.

Profile summary based on public USPTO records.